摘要
Osteoporosis is a common bone disease that is characterized by decreased bone density and is associated with an increased risk of fractures. Due to increased life expectancy, the number of patients with osteoporosis, and thus, osteoporosis-associated complications, such as fractures, are expected to increase further in the near future） Therefore, the development of new treatment strategies is essential, as treatment with bisphosphonates, which is the gold standard treatment for osteoporosis, is not recommended for and is not well tolerated by all patients.
Osteoporosis is a common bone disease that is characterized by decreased bone density and is associated with an increased risk of fractures. Due to increased life expectancy, the number of patients with osteoporosis, and thus, osteoporosis-associated complications, such as fractures, are expected to increase further in the near future） Therefore, the development of new treatment strategies is essential, as treatment with bisphosphonates, which is the gold standard treatment for osteoporosis, is not recommended for and is not well tolerated by all patients.
